8-K
Current Report
C4 Therapeutics, Inc. Filed Acc 0001564590-21-022516
Executive or director change
- Item 5.02 Departure or appointment of directors or officers
From the SEC's structured data for this filing
Loading cccc-8k_20210427.htm…